VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart
Open Access
- 22 February 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 91 (3), 402-411
- https://doi.org/10.1093/cvr/cvr053
Abstract
The objective of this study was to investigate whether vascular endothelial growth factor (VEGF) secreted by mesenchymal stem cells (MSC) improves myocardial survival and the engraftment of implanted MSC in infarcted hearts and promotes recruitment of stem cells through paracrine release of myocardial stromal cell-derived factor-1α (SDF-1α). VEGF-expressing MSC (VEGFMSC)-conditioned medium enhanced SDF-1α expression in heart slices and H9C2 cardiomyoblast cells via VEGF and the vascular endothelial growth factor receptor (VEGFR). The VEGFMSC-conditioned medium markedly promoted cardiac stem cell (CSC) migration at least in part via the SDF-1α/CXCR4 pathway and involved binding to VEGFR-1 and VEGFR-3. In vivo, VEGFMSC-stimulated SDF-1α expression in infarcted hearts resulted in massive mobilization and homing of bone marrow stem cells and CSC. Moreover, VEGF-induced SDF-1α guided the exogenously introduced CSC in the atrioventricular groove to migrate to the infarcted area, leading to a reduction in infarct size. Functional studies showed that VEGFMSC transplantation stimulated extensive angiomyogenesis in infarcted hearts as indicated by the expression of cardiac troponin T, CD31, and von Willebrand factor and improved the left ventricular performance, whereas blockade of SDF-1α or its receptor by RNAi or antagonist significantly diminished the beneficial effects of VEGFMSC. Exogenously expressed VEGF promotes myocardial repair at least in part through SDF-1α/CXCR4-mediated recruitment of CSC.Keywords
This publication has 37 references indexed in Scilit:
- Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine SignalingCirculation Research, 2006
- The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction modelCardiovascular Research, 2006
- Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvementThe FASEB Journal, 2006
- An SDF-1 Trap for Myeloid Cells Stimulates AngiogenesisCell, 2006
- Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cellsJournal of Molecular and Cellular Cardiology, 2005
- Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarctionJournal of Biomedical Science, 2005
- How do stem cells find their way home?Blood, 2005
- Vascular Endothelial Growth Factor–Expressing Mesenchymal Stem Cell Transplantation for the Treatment of Acute Myocardial InfarctionArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cellsNature Medicine, 2005
- Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia ModelCirculation, 2005